NSAIDs, sedative-hypnotics, alcohols, anti-seizure, anes, anti-parkinsons Flashcards
nonselective irreversible cox1 and 2 inhibitor, reduces plt production of TXA2, stimulator of plt aggregation; duration of use for arterial thrombosis; associated with ___ in children; prevents uric acid _______so (must/ must not) be used in gout
ASA; 8-10 days(plt lifespan); Reye syndrome; excretion; must not
ASA dose effective for reducing platelet aggregation; follows ____ order elimination
<300mg/day; first order
ASA dose effective as anti-inflamm; follows ____ order elimination
2400-4000mg/d; zero order
ASA intermediate dose for
antipyretic and analgesic
ASA toxic dose
150mg/kg (21 ASA 500mg tabs)
ASA lethal dose
30g (60 500mg tabs)
nonselective reversible cox1 and 2 inhibitor, inhibits prostaglandin synthesis; long-term use reduces risk of ___
ibuprofen, diclofenac, mefanamic acid, meloxicam, piroxicam; colon CA
prevents NSAID-induced gastritis
misoprostol
COX 2>COX1
meloxicam, peroxicam
only IV NSAID, used for post-surgical analgesia; purely analgesic, no anti-inflamm; use for ___ hrs only
Ketorolac; 72
nonselective reversible COX inhibitor used for gout and closure of PDA; special SE
indomethacin; hematologic (aplastic anemia, thrombocytopenia)
selective Cox-2 inhibitor; available IV form; risk for MI and stroke
celecoxib; parecoxib; rofecoxib and valdecoxib
selective Cox-3 inhibitor, weak effect on cox1 and 2; MC SE especially with _____ use; antidote
Paracetamol; hepatotoxicity; alcohol; NAC
similar drug of paracetamol which can cause renal papillary necrosis and interstitial nephritis
phenacetin
in Paracetamol toxicity, ____ accumulates due to oxidation by ______; region of liver preferentially involved
NAPQ1 (N-acetyl-p-benzoquinoneimime); CYP2E1; centrilobular region (zone III)
paracetamol toxic dose; lethal dose
150mg/kg; 15g
MOA of MTX; first choice DMARD for tx of ____; rescue agent
inhibits AICAR transformylase and thymidylate synthetase with secondary effects on PMN chemotaxis; RA; leucovorin (folinic acid)
binds to TNF-a; used for Crohn’s disease, TV reactivation, lymphoma; synergistic effect w/ MTX
infliximab, etanercept
forms 6-thioguianine (purine anti-metabolite) which suppresses inosinic acid synthesis, b and t-cell function, Ig production and IL-2 secretion; similar MOA with ____ (chemotx); don’t give with ____
azathioprine; mercaptopurine; allopurinol
DMARD also anti-malarial; SE; safe for pregnant?
chloroquine; ocular toxicity (retinal reposits); safe
forms phosphoramide mustard which cross-links DNA to prevent replication, supresses t-cell and b-cell; metabolite ____ causes_____; rescue agent
cyclophosphamide; acrolein; hemorrhagic cystits; mesna
inhibits IL-1 and IL-2 receptor production, secondarily inhibits macrophage t-cell interaction and t-cell responsiveness; SE
cyclosporine; gingival hyperplasia
inhibits inosine monophosphate dehydrogenase (impt in guanine synthesis), inhibits T-cell proliferation; SE
mycophenolate mofetil; reversible myelosuppression
DMARD which inhibits release of inflamm cytokines; SE
sulfasalazine; hemolytic anemia, methemoglobinemia; reversible infertility in men